Genetic Disorders Duchenne Muscular Dystrophy Diagnosis Treatment Options Patient Advocacy Batten Disease Patient Care Primary Immunodeficiencies Neurological Disorders Lysosomal Storage Disorders Kidney Diseases Congenital Disorders Diagnosis and Treatment Hemophilia Genetic Conditions Pediatric Rare Diseases Autoimmune Disorders Drug Development Metabolic Disorders Innovative Treatments Prader-Willi Syndrome Childhood Cancer Spinal Muscular Atrophy Muscular Dystrophy Transthyretin Amyloidosis Drug Sales Lymphatic Disorders Mucopolysaccharidosis Friedreich's Ataxia Clinical Trials IDIC 15 Orphan Diseases SMA FDA Regulations Hereditary Angioedema Cardiomyopathy Neurodevelopmental Disorders Muscle Disorders Cerebral Folate Deficiency Pediatric Disorders Pulmonary Hypertension Sickle Cell Anemia Advocacy Amyloidosis Research Initiatives Fibrodysplasia Ossificans Progressiva Nephrology Emoglobinuria Parossistica Notturna Lymphatic Malformations National Policy for Rare Diseases Complement-driven Diseases Inherited Anaemias Neurofibromatosis Sarcomas Leukocyte Adhesion Deficiency Desmoid Tumors Government Policy Niemann-Pick Disease Epidemiology Acondroplasia Arthrogryposis Support Organizations Mitochondrial Diseases Therapeutic Innovations Hyperinsulinism Hereditary Hemorrhagic Telangiectasia Screening Programs Liver Diseases Pediatric Conditions Regulatory Framework Erythropoietic Protoporphyria Brain Tumors Treatment Development Inherited Disorders Autosomal Dominant Polycystic Kidney Disease Systemic Mastocytosis Drug Accessibility Genetic Diagnosis Research Cancer Treatments Custom Therapies Genomic Research WHIM Syndrome Pompe Disease Research Foundations Orphan Drugs Drug Safety Orphan Drug Designation Neuroendocrine Disorders Cholangiocarcinoma AnWj-negative Individuals Patient Populations Therapeutics Development Metachromatic Leukodystrophy Clinical Genetics Hemophagocytic Lymphohistiocytosis Subacute Sclerosing Panencephalitis Gene Therapy Creatine Transporter Deficiency Support Networks
The Prime Video series shows treatment for her twins was postponed and warns that a phased roll‑out of heel‑prick screening could leave many babies without early diagnosis.
